Crossmark

755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial

Crossref DOI link: https://doi.org/10.1007/s10103-024-04052-9

Published Online: 2024-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Dihui

Cheng, Shaowei

Zhou, Shaona

Hao, Jianchun

Chen, Hongguang

Jia, Kang

Liu, Hongmei

Cui, Yong
License Information

Text and Data Mining valid from 2024-04-24

Version of Record valid from 2024-04-24
More Information

Article History

Received: 9 November 2023

Accepted: 7 April 2024

First Online: 24 April 2024

Conflicts of interest

: The authors declared no potential conflicts of interest in this work.

Document is current

Any future updates will be listed below